FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:VPS33A-ATXN2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: VPS33A-ATXN2
FusionPDB ID: 98376
FusionGDB2.0 ID: 98376
HgeneTgene
Gene symbol

VPS33A

ATXN2

Gene ID

65082

6311

Gene nameVPS33A core subunit of CORVET and HOPS complexesataxin 2
SynonymsMPSPSATX2|SCA2|TNRC13
Cytomap

12q24.31

12q24.12

Type of geneprotein-codingprotein-coding
Descriptionvacuolar protein sorting-associated protein 33AVPS33A, CORVET/HOPS core subunitvacuolar protein sorting 33 homolog Avacuolar protein sorting 33Aataxin-2spinocerebellar ataxia type 2 proteintrinucleotide repeat-containing gene 13 protein
Modification date2020031320200313
UniProtAcc.

Q8WWM7

Main function of 5'-partner protein: FUNCTION: Involved in the regulation of stress granule and P-body formation. {ECO:0000269|PubMed:23209657}.
Ensembl transtripts involved in fusion geneENST idsENST00000267199, ENST00000451053, 
ENST00000542310, 
ENST00000549455, 
ENST00000377617, ENST00000389153, 
ENST00000535949, ENST00000542287, 
ENST00000550104, ENST00000608853, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score6 X 8 X 5=24021 X 19 X 10=3990
# samples 827
** MAII scorelog2(8/240*10)=-1.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(27/3990*10)=-3.88535743405888
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: VPS33A [Title/Abstract] AND ATXN2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: VPS33A [Title/Abstract] AND ATXN2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)VPS33A(122745808)-ATXN2(111926584), # samples:1
Anticipated loss of major functional domain due to fusion event.VPS33A-ATXN2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
VPS33A-ATXN2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
VPS33A-ATXN2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
VPS33A-ATXN2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneVPS33A

GO:0016192

vesicle-mediated transport

15790593

HgeneVPS33A

GO:0032400

melanosome localization

15790593

HgeneVPS33A

GO:0032418

lysosome localization

15790593



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:122745808/chr12:111926584)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across VPS33A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ATXN2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000267199VPS33Achr12122745808-ENST00000389153ATXN2chr12111926584-2727596412128695
ENST00000267199VPS33Achr12122745808-ENST00000608853ATXN2chr12111926584-2721596412122693
ENST00000267199VPS33Achr12122745808-ENST00000377617ATXN2chr12111926584-2721596412122693
ENST00000267199VPS33Achr12122745808-ENST00000550104ATXN2chr12111926584-2606596411168375
ENST00000267199VPS33Achr12122745808-ENST00000542287ATXN2chr12111926584-2256596412197718
ENST00000267199VPS33Achr12122745808-ENST00000535949ATXN2chr12111926584-2127596412068675
ENST00000451053VPS33Achr12122745808-ENST00000389153ATXN2chr12111926584-262249182023671
ENST00000451053VPS33Achr12122745808-ENST00000608853ATXN2chr12111926584-261649182017669
ENST00000451053VPS33Achr12122745808-ENST00000377617ATXN2chr12111926584-261649182017669
ENST00000451053VPS33Achr12122745808-ENST00000550104ATXN2chr12111926584-250149181063351
ENST00000451053VPS33Achr12122745808-ENST00000542287ATXN2chr12111926584-215149182092694
ENST00000451053VPS33Achr12122745808-ENST00000535949ATXN2chr12111926584-202249181963651

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000267199ENST00000389153VPS33Achr12122745808-ATXN2chr12111926584-0.0069932110.9930068
ENST00000267199ENST00000608853VPS33Achr12122745808-ATXN2chr12111926584-0.006693450.9933066
ENST00000267199ENST00000377617VPS33Achr12122745808-ATXN2chr12111926584-0.006693450.9933066
ENST00000267199ENST00000550104VPS33Achr12122745808-ATXN2chr12111926584-0.0018428380.9981572
ENST00000267199ENST00000542287VPS33Achr12122745808-ATXN2chr12111926584-0.0179014840.98209846
ENST00000267199ENST00000535949VPS33Achr12122745808-ATXN2chr12111926584-0.0183978530.98160213
ENST00000451053ENST00000389153VPS33Achr12122745808-ATXN2chr12111926584-0.0085147550.9914853
ENST00000451053ENST00000608853VPS33Achr12122745808-ATXN2chr12111926584-0.0081836820.99181634
ENST00000451053ENST00000377617VPS33Achr12122745808-ATXN2chr12111926584-0.0081836820.99181634
ENST00000451053ENST00000550104VPS33Achr12122745808-ATXN2chr12111926584-0.0022008550.9977991
ENST00000451053ENST00000542287VPS33Achr12122745808-ATXN2chr12111926584-0.0215188790.9784812
ENST00000451053ENST00000535949VPS33Achr12122745808-ATXN2chr12111926584-0.0231409910.97685903

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for VPS33A-ATXN2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
VPS33Achr12122745808ATXN2chr12111926584491161GDLLSMESEGAFKLQPSSTSESMDQL
VPS33Achr12122745808ATXN2chr12111926584596185GDLLSMESEGAFKLQPSSTSESMDQL

Top

Potential FusionNeoAntigen Information of VPS33A-ATXN2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
VPS33A-ATXN2_122745808_111926584.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B13:01MESEGAFKL0.99910.8817514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B45:01SEGAFKLQP0.9970.9906716
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:02MESEGAFKL0.99650.5588514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:03MESEGAFKL0.99490.9646514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B47:01MESEGAFKL0.99330.523514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:02SEGAFKLQP0.99230.8476716
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:01MESEGAFKL0.98690.8832514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B45:01MESEGAFKL0.98210.9287514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:13MESEGAFKL0.65430.9746514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B38:01MESEGAFKL0.64920.9768514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B41:01SEGAFKLQP0.63350.9789716
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:01MESEGAFKL0.6280.9678514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B38:02MESEGAFKL0.61640.9828514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B41:01MESEGAFKL0.49520.9802514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:01MESEGAFKL0.44270.7434514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:01SEGAFKLQP0.33890.8841716
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B15:10MESEGAFKL0.31610.7257514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B15:37MESEGAFKL0.25350.6986514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B47:01SMESEGAFKL0.68370.5769414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:03SMESEGAFKL0.48230.9742414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:13SMESEGAFKL0.38910.9451414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B45:01MESEGAFKLQP0.99940.9888516
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B40:06MESEGAFKL0.99970.6165514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B40:06SEGAFKLQP0.99220.8795716
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:05MESEGAFKL0.61150.9596514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:12MESEGAFKL0.58130.9681514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:08MESEGAFKL0.56190.8995514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:08SMESEGAFKL0.78750.808414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B07:12KLQPSSTSESM0.98510.59591223
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B40:04MESEGAFKL0.99950.6937514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:13MESEGAFKL0.99490.9646514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:26MESEGAFKL0.99490.9646514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:07MESEGAFKL0.99490.9646514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:04MESEGAFKL0.99330.8926514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:07MESEGAFKL0.99130.8581514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:08MESEGAFKL0.98790.8604514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:05MESEGAFKL0.98690.8832514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:06MESEGAFKL0.98040.8877514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:03MESEGAFKL0.97110.8795514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B18:11MESEGAFKL0.85050.9437514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B41:03MESEGAFKL0.66030.6556514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:31MESEGAFKL0.65650.9665514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B38:05MESEGAFKL0.64920.9768514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:02MESEGAFKL0.6230.9722514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:11MESEGAFKL0.54120.8797514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B48:02MESEGAFKL0.4530.9077514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:04MESEGAFKL0.44270.7434514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:05MESEGAFKL0.44270.7434514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:04SEGAFKLQP0.33890.8841716
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B50:05SEGAFKLQP0.33890.8841716
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B35:20MESEGAFKL0.27870.9282514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B15:09MESEGAFKL0.13950.6112514
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B39:02SMESEGAFKL0.61060.9463414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B40:04SMESEGAFKL0.59360.6313414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:13SMESEGAFKL0.48230.9742414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:26SMESEGAFKL0.48230.9742414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B44:07SMESEGAFKL0.48230.9742414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B41:03SMESEGAFKL0.36530.5195414
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B15:73KLQPSSTSESM0.99560.97321223
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B15:30KLQPSSTSESM0.99370.92191223
VPS33A-ATXN2chr12122745808chr12111926584596HLA-B67:01KLQPSSTSESM0.61980.97441223

Top

Potential FusionNeoAntigen Information of VPS33A-ATXN2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
VPS33A-ATXN2_122745808_111926584.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0401SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0401EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0401ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0401GAFKLQPSSTSESMD924
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0407EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0407SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0419SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0419EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0419ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0427AFKLQPSSTSESMDQ1025
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0431EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0431SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0433SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0433EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0433ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0433GAFKLQPSSTSESMD924
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0434SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0434EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0434ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0435SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0435EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0435ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0438SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0438EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0438ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0438GAFKLQPSSTSESMD924
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0443SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0443EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0447SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0447EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0451AFKLQPSSTSESMDQ1025
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0454SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0454EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0461SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0461EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0461ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0462SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0462EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0463SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0463EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0463ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0463GAFKLQPSSTSESMD924
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0464SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0464EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0464ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0472EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0472SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0472ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0474EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0474SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0475SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0475EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0475ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0476SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0476EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0476ESEGAFKLQPSSTSE621
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-0476GAFKLQPSSTSESMD924
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-1001EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-1001SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-1003EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-1003SEGAFKLQPSSTSES722
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-1446EGAFKLQPSSTSESM823
VPS33A-ATXN2chr12122745808chr12111926584596DRB1-1446SEGAFKLQPSSTSES722

Top

Fusion breakpoint peptide structures of VPS33A-ATXN2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
2120ESEGAFKLQPSSTSVPS33AATXN2chr12122745808chr12111926584596

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of VPS33A-ATXN2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN2120ESEGAFKLQPSSTS-7.15543-7.26883
HLA-B14:023BVN2120ESEGAFKLQPSSTS-4.77435-5.80965
HLA-B52:013W392120ESEGAFKLQPSSTS-6.80875-6.92215
HLA-B52:013W392120ESEGAFKLQPSSTS-4.20386-5.23916
HLA-A11:014UQ22120ESEGAFKLQPSSTS-7.5194-8.5547
HLA-A11:014UQ22120ESEGAFKLQPSSTS-6.9601-7.0735
HLA-A24:025HGA2120ESEGAFKLQPSSTS-7.52403-7.63743
HLA-A24:025HGA2120ESEGAFKLQPSSTS-5.82433-6.85963
HLA-B27:056PYJ2120ESEGAFKLQPSSTS-3.28285-4.31815
HLA-B44:053DX82120ESEGAFKLQPSSTS-5.91172-6.94702
HLA-B44:053DX82120ESEGAFKLQPSSTS-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of VPS33A-ATXN2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
VPS33A-ATXN2chr12122745808chr121119265841223KLQPSSTSESMAAATTACAGCCAAGTTCTACTTCTGAATCTATG
VPS33A-ATXN2chr12122745808chr12111926584414SMESEGAFKLTCCATGGAATCAGAGGGTGCATTCAAATTA
VPS33A-ATXN2chr12122745808chr12111926584514MESEGAFKLATGGAATCAGAGGGTGCATTCAAATTA
VPS33A-ATXN2chr12122745808chr12111926584516MESEGAFKLQPATGGAATCAGAGGGTGCATTCAAATTACAGCCA
VPS33A-ATXN2chr12122745808chr12111926584716SEGAFKLQPTCAGAGGGTGCATTCAAATTACAGCCA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
VPS33A-ATXN2chr12122745808chr121119265841025AFKLQPSSTSESMDQGCATTCAAATTACAGCCAAGTTCTACTTCTGAATCTATGGATCAA
VPS33A-ATXN2chr12122745808chr12111926584621ESEGAFKLQPSSTSEGAATCAGAGGGTGCATTCAAATTACAGCCAAGTTCTACTTCTGAA
VPS33A-ATXN2chr12122745808chr12111926584722SEGAFKLQPSSTSESTCAGAGGGTGCATTCAAATTACAGCCAAGTTCTACTTCTGAATCT
VPS33A-ATXN2chr12122745808chr12111926584823EGAFKLQPSSTSESMGAGGGTGCATTCAAATTACAGCCAAGTTCTACTTCTGAATCTATG
VPS33A-ATXN2chr12122745808chr12111926584924GAFKLQPSSTSESMDGGTGCATTCAAATTACAGCCAAGTTCTACTTCTGAATCTATGGAT

Top

Information of the samples that have these potential fusion neoantigens of VPS33A-ATXN2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LGGVPS33A-ATXN2chr12122745808ENST00000267199chr12111926584ENST00000377617TCGA-DU-6397-02A

Top

Potential target of CAR-T therapy development for VPS33A-ATXN2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to VPS33A-ATXN2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to VPS33A-ATXN2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource